Related Experiment Videos
Some observations on the opiate peptides and schizophrenia
Archives of General Psychiatry
|January 1, 1979
Summary
Opiate peptides, like beta-endorphin, are studied for their role in schizophrenia. Research explores their connection to dopamine and stress, potentially altering symptoms with antagonists.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- The discovery of opiate peptides opened new research avenues.
- Opiate peptides have garnered significant attention regarding their anatomy, biochemistry, and physiology.
Purpose of the Study:
- To provide an overview of key research issues and recent findings in the field of opiate peptides.
- To discuss the potential link between opiate peptide neuronal systems and schizophrenia.
Main Methods:
- Review of existing research on opiate peptides.
- Analysis of studies attempting to modify schizophrenic symptoms using opiate antagonists, beta-endorphin, and dialysis.
Main Results:
- Exploration of the anatomical, biochemical, and physiological aspects of opiate peptides.
- Investigation into the therapeutic potential of opiate-related interventions for schizophrenia.
Conclusions:
- The involvement of opiate peptides in schizophrenia is hypothesized.
- If opiate peptides are implicated in schizophrenia, their interaction with dopamine systems and/or stress responses may be crucial.